# CYP4V2

## Overview
CYP4V2 is a gene that encodes the cytochrome P450 family 4 subfamily V member 2, a member of the cytochrome P450 superfamily of enzymes. This enzyme is primarily involved in the metabolism of fatty acids, particularly through the omega-hydroxylation of saturated medium-chain fatty acids, and plays a significant role in lipid homeostasis and energy production. The CYP4V2 protein is predominantly expressed in the epithelial cells of the retina and cornea, where it contributes to the metabolism of ω-3 polyunsaturated fatty acids, essential for maintaining retinal health and function (Yi2017Expression; Kumar2011Comparative). Mutations in the CYP4V2 gene are linked to ocular diseases such as Bietti's crystalline dystrophy and retinitis pigmentosa, highlighting its clinical significance in retinal degenerative conditions (Kelly2011Finding; Zou2022Identification).

## Structure
The CYP4V2 protein is encoded by the CYP4V2 gene, which consists of 11 exons and encodes a 525 amino acid protein (Jarrar2019Molecular; Kumar2011Comparative). The primary structure of CYP4V2 includes several conserved motifs characteristic of the cytochrome P450 superfamily, such as the FxxGxxxCxG motif, which is crucial for its enzymatic function (Kumar2011Comparative). The secondary structure of CYP4V2 likely includes alpha-helices and beta-sheets, typical of cytochrome P450 proteins, although specific details are not provided in the context.

The tertiary structure of CYP4V2 has been modeled using homology modeling techniques, as its crystal structure has not been resolved. This model preserves the overall CYP fold and includes conserved regions similar to other P450 enzymes (Kumar2011Comparative). The model was refined through energy minimization and assessed for structural quality, showing reliability with 98.5% of residues in the allowed region (Kumar2011Comparative).

There is no information provided on the quaternary structure or post-translational modifications of CYP4V2. The protein is involved in the omega-hydroxylation of saturated medium-chain fatty acids, which is crucial for its role in fatty acid metabolism (Kumar2011Comparative).

## Function
The CYP4V2 gene encodes a cytochrome P450 enzyme involved in the metabolism of endogenous fatty acids, playing a crucial role in lipid homeostasis and energy production. This enzyme is part of the CYP4 family and is primarily active in the endoplasmic reticulum. It is notably expressed in the epithelial cells of the retina and cornea, where it is expected to perform fatty acid metabolism, particularly in the omega-hydroxylation of saturated medium-chain fatty acids (Yi2017Expression; Kumar2011Comparative).

CYP4V2 is involved in the metabolism of ω-3 polyunsaturated fatty acids (PUFAs) in the retinal pigment epithelium (RPE) cells, which are essential for photoreceptor function. The enzyme hydroxylates ω-3 PUFAs, such as DHA and EPA, which are precursors to metabolites with anti-inflammatory and immunoregulatory properties (Kelly2011Finding). In macrophages, CYP4V2 is involved in fatty acid metabolism, crucial for the transformation of macrophages into foam cells, a primary lesion in atherosclerosis. Its expression in human THP1 macrophages is regulated by peroxisome proliferator-activated receptor gamma (PPARγ), indicating its role in lipid metabolism and potential implications in cardiovascular diseases (Yi2017Expression).

## Clinical Significance
Mutations in the CYP4V2 gene are primarily associated with Bietti's crystalline dystrophy (BCD), a rare autosomal recessive ocular disease characterized by crystalline deposits in the retina and choroid, leading to progressive vision loss. BCD is linked to over twenty mutations in CYP4V2, with common mutations including splice-site mutations that result in exon deletions, causing significant structural changes and loss of enzyme activity (Kelly2011Finding; Nakano2012CYP4V2). These mutations disrupt fatty acid metabolism, particularly affecting the ω-hydroxylation of polyunsaturated fatty acids, which is crucial for retinal health (Kelly2011Finding).

CYP4V2 mutations have also been implicated in autosomal recessive retinitis pigmentosa (RP), another retinal degenerative disease. In a Chinese family, a novel compound heterozygous variant in CYP4V2 was identified, consisting of mutations p.R320X and p.R452H, which are predicted to be pathogenic and alter the protein's structure and function (Zou2022Identification). These findings highlight the gene's role in various retinal diseases and underscore the complexity of genetic interactions and the influence of genetic modifiers on disease phenotypes (Zou2022Identification; Darki2019CYP4V2).

## Interactions



## References


[1. (Nakano2012CYP4V2) Mariko Nakano, Edward J. Kelly, Constanze Wiek, Helmut Hanenberg, and Allan E. Rettie. Cyp4v2 in bietti’s crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.h331p variant. Molecular Pharmacology, 82(4):679–686, July 2012. URL: http://dx.doi.org/10.1124/mol.112.080085, doi:10.1124/mol.112.080085. This article has 85 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.112.080085)

[2. (Kumar2011Comparative) Suresh Kumar. Comparative modeling and molecular docking of orphan human cyp4v2 protein with fatty acid substrates: insights into substrate specificity. Bioinformation, 7(7):360–365, December 2011. URL: http://dx.doi.org/10.6026/97320630007360, doi:10.6026/97320630007360. This article has 13 citations.](https://doi.org/10.6026/97320630007360)

[3. (Kelly2011Finding) E. J. Kelly, M. Nakano, P. Rohatgi, V. Yarov-Yarovoy, and A. E. Rettie. Finding homes for orphan cytochrome p450s: cyp4v2 and cyp4f22 in disease states. Molecular Interventions, 11(2):124–132, April 2011. URL: http://dx.doi.org/10.1124/mi.11.2.10, doi:10.1124/mi.11.2.10. This article has 41 citations.](https://doi.org/10.1124/mi.11.2.10)

[4. (Zou2022Identification) Tongdan Zou, Ting Wang, Fangyuan Zhen, Shuqian Dong, Bo Gong, and Houbin Zhang. Identification of a novel compound heterozygous cyp4v2 variant in a patient with autosomal recessive retinitis pigmentosa. Biomedical Reports, March 2022. URL: http://dx.doi.org/10.3892/br.2022.1523, doi:10.3892/br.2022.1523. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/br.2022.1523)

[5. (Jarrar2019Molecular) Yazun Bashir Jarrar and Su-Jun Lee. Molecular functionality of cytochrome p450 4 (cyp4) genetic polymorphisms and their clinical implications. International Journal of Molecular Sciences, 20(17):4274, August 2019. URL: http://dx.doi.org/10.3390/ijms20174274, doi:10.3390/ijms20174274. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20174274)

[6. (Yi2017Expression) Myeongjin Yi, Jae-Gook Shin, and Su-Jun Lee. Expression of cyp4v2 in human thp1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gamma. Toxicology and Applied Pharmacology, 330:100–106, September 2017. URL: http://dx.doi.org/10.1016/j.taap.2017.07.009, doi:10.1016/j.taap.2017.07.009. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.taap.2017.07.009)

[7. (Darki2019CYP4V2) Faezeh Darki, Sahba Fekri, Shaghayegh Farhangmehr, Hamid Ahmadieh, Mohammad Hossein Dehghan, and Elahe Elahi. Cyp4v2 mutation screening in an iranian bietti crystalline dystrophy pedigree and evidence for clustering of cyp4v2 mutations. Journal of Current Ophthalmology, 31(2):172–179, June 2019. URL: http://dx.doi.org/10.1016/j.joco.2019.01.007, doi:10.1016/j.joco.2019.01.007. This article has 3 citations.](https://doi.org/10.1016/j.joco.2019.01.007)